Grace Yang, general manager of TSH Biopharm, discusses how the company is uniquely positioned to deliver end-to-end healthcare solutions to the APAC region in the areas of cardiovascular, gastrointestinal, autoimmune, central nervous system, and why TSH step in to cancer diagnosis business area. Yang goes on to explain how TSH can play a role as an experienced & strategic licensing partner for industry players looking to tap into the complex Southeast Asian markets.
To strengthen the business, my priority has been incorporating more innovation into the TSH model.
